Arcus Biosciences Inc.
News
Arcus Biosciences Announces New Employment Inducement Grants
Business Wire Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today...\n more…
Arcus Biosciences (NYSE:RCUS) Trading Down 3.5%
Ticker Report Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report)'s stock price was down 3.5% during trading on Friday . The stock traded as low as $16.68 and last traded at $16.73. Approximately 85,619 shares...\n more…
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Grows Holdings in Arcus Biosciences, Inc. (NYSE:RCUS)
Zolmax BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its position in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 8.7% during the 2nd quarter, Holdings Channel reports. The firm...\n more…
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $11.34 Million Holdings in Arcus Biosciences, Inc. (NYSE:RCUS)
Ticker Report BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 8.7% in the second quarter, according to the company in its most recent filing...\n more…
Arcus Biosciences, Inc. (NYSE:RCUS) Receives $34.13 Consensus Price Target from Analysts
Ticker Report Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) has earned a consensus rating of "Buy" from the nine brokerages that are currently covering the stock, MarketBeat reports. One research analyst...\n more…
Arcus Biosciences secures $250M term loan facility
Seeking Alpha - Healthcare Arcus Biosciences secures $250M term loan facility...\n more…